Management of RSV infections in adult recipients of hematopoietic stem cell transplantation

Detection and Control of a Nosocomial Respiratory Syncytial Virus Outbreak in a Stem Cell Transplantation Unit: The Role of Palivizumab

(2010) Christelle Kassis et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Pharmacotherapy of respiratory syncytial virus infection

(2010) Robert C Welliver   CURRENT OPINION IN PHARMACOLOGY

Treatment of respiratory syncytial virus infection in haemopoietic stem cell transplant recipients with aerosolized ribavirin and the humanized monoclonal antibody palivizumab: a single centre experience

(2009) Dimitris A. Tsitsikas et al.   BRITISH JOURNAL OF HAEMATOLOGY

Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation

(2009) J. T. Schiffer et al.   HAEMATOLOGICA

Therapeutic Monoclonal Antibody Treatment Targeting Respiratory Syncytial Virus (RSV) G Protein Mediates Viral Clearance and Reduces the Pathogenesis of RSV Infection in BALB/c Mice

(2009) Lia M. Haynes et al.   JOURNAL OF INFECTIOUS DISEASES

Motavizumab for Prophylaxis of Respiratory Syncytial Virus in High-Risk Children: A Noninferiority Trial

(2009) X. Carbonell-Estrany et al.   PEDIATRICS

Comparison of conventional and molecular detection of respiratory viruses in hematopoietic cell transplant recipients

(2009) J. Kuypers et al.   Transplant Infectious Disease

Respiratory Syncytial Virus Infection in Recipients of Allogeneic Stem-Cell Transplantation: A Retrospective Study of the Incidence, Clinical Features, and Outcome

(2009) Gayane Avetisyan et al.   TRANSPLANTATION

Palivizumab: where to from here?

(2008) Georgiana Georgescu et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Respiratory Syncytial Virus Infection in Patients with Hematological Diseases: Single-Center Study and Review of the Literature

(2007) N. Khanna et al.   CLINICAL INFECTIOUS DISEASES